Literature DB >> 19429478

Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus replication.

Shara N Pantry1, Peter G Medveczky.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is the causative agent of Kaposi's sarcoma and B-lymphocyte disorders, primary effusion lymphoma (PEL) and Multicentric Castleman's Disease (MCD). KSHV usually exists in a latent form in which the viral genome is circularized into an extrachormosomal episome. However, induction of lytic replication by environmental stimuli or chemical agents is important for the spread of KSHV. The switch between latency and lytic replication is regulated by epigenetic factors. Hypomethylation of the promoter of replication and transcription activator (RTA), which is essential for the lytic switch, leads to KSHV reactivation. Histone acetylation induces KSHV replication by influencing protein-protein-associations and transcription factor binding. Histone modifications also determine chromatin structure and nucleosome positioning, which are important for KSHV DNA replication during latency. The association of KSHV proteins with chromatin remodeling complexes promotes the open chromatin structure needed for transcription factor binding and DNA replication. Additionally, post-translational modification of KSHV proteins is important for the regulation of RTA activity and KSHV replication. KSHV may also cause epigenetic modification of the host genome, contributing to promoter hypermethylation of tumor suppressor genes in KSHV-associated neoplasias.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19429478      PMCID: PMC2753186          DOI: 10.1016/j.semcancer.2009.02.010

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  47 in total

Review 1.  Kaposi's sarcoma-associated herpesvirus immediate early gene activity.

Authors:  Vincent Lacoste; Cynthia de la Fuente; Fatah Kashanchi; Anne Pumfery
Journal:  Front Biosci       Date:  2004-09-01

2.  The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions.

Authors:  R Renne; M Lagunoff; W Zhong; D Ganem
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

3.  Coordinated regulation of apoptosis and cell proliferation by transforming growth factor beta 1 in cultured uterine epithelial cells.

Authors:  R J Rotello; R C Lieberman; A F Purchio; L E Gerschenson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

4.  A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus.

Authors:  R Sun; S F Lin; L Gradoville; Y Yuan; F Zhu; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

5.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

Authors:  E Cesarman; Y Chang; P S Moore; J W Said; D M Knowles
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

6.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

Authors:  Y Chang; E Cesarman; M S Pessin; F Lee; J Culpepper; D M Knowles; P S Moore
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

7.  Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein.

Authors:  D M Lukac; R Renne; J R Kirshner; D Ganem
Journal:  Virology       Date:  1998-12-20       Impact factor: 3.616

8.  Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection.

Authors:  G Miller; M O Rigsby; L Heston; E Grogan; R Sun; C Metroka; J A Levy; S J Gao; Y Chang; P Moore
Journal:  N Engl J Med       Date:  1996-05-16       Impact factor: 91.245

9.  Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway.

Authors:  Shizhen Emily Wang; Frederick Y Wu; Honglin Chen; Meir Shamay; Qizhi Zheng; Gary S Hayward
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

10.  The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients.

Authors:  L L Decker; P Shankar; G Khan; R B Freeman; B J Dezube; J Lieberman; D A Thorley-Lawson
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

View more
  30 in total

1.  Kaposi's Sarcoma-Associated Herpesvirus Utilizes and Manipulates RNA N6-Adenosine Methylation To Promote Lytic Replication.

Authors:  Fengchun Ye; E Ricky Chen; Timothy W Nilsen
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

2.  Short-chain fatty acids from periodontal pathogens suppress histone deacetylases, EZH2, and SUV39H1 to promote Kaposi's sarcoma-associated herpesvirus replication.

Authors:  Xiaolan Yu; Abdel-Malek Shahir; Jingfeng Sha; Zhimin Feng; Betty Eapen; Stanley Nithianantham; Biswajit Das; Jonathan Karn; Aaron Weinberg; Nabil F Bissada; Fengchun Ye
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

3.  Quantitative analysis of the bidirectional viral G-protein-coupled receptor and lytic latency-associated nuclear antigen promoter of Kaposi's sarcoma-associated herpesvirus.

Authors:  Isaac B Hilton; Dirk P Dittmer
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

Review 4.  Recent advances in the study of Kaposi's sarcoma-associated herpesvirus replication and pathogenesis.

Authors:  Denis Avey; Brittany Brewers; Fanxiu Zhu
Journal:  Virol Sin       Date:  2015-04-23       Impact factor: 4.327

5.  Virus reactivation: a panoramic view in human infections.

Authors:  Christopher M Traylen; Hersh R Patel; Wylder Fondaw; Sheran Mahatme; John F Williams; Lia R Walker; Ossie F Dyson; Sergio Arce; Shaw M Akula
Journal:  Future Virol       Date:  2011-04       Impact factor: 1.831

Review 6.  Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention.

Authors:  Abhik Saha; Rajeev Kaul; Masanao Murakami; Erle S Robertson
Journal:  Cancer Biol Ther       Date:  2010-11-15       Impact factor: 4.742

7.  An in vitro system for studying murid herpesvirus-4 latency and reactivation.

Authors:  Janet S May; Neil J Bennett; Philip G Stevenson
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

8.  Cohesins repress Kaposi's sarcoma-associated herpesvirus immediate early gene transcription during latency.

Authors:  Horng-Shen Chen; Priyankara Wikramasinghe; Louise Showe; Paul M Lieberman
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

Review 9.  Epigenetic regulation of EBV and KSHV latency.

Authors:  Horng-Shen Chen; Fang Lu; Paul M Lieberman
Journal:  Curr Opin Virol       Date:  2013-04-16       Impact factor: 7.090

Review 10.  Diversity and evolution of chromatin proteins encoded by DNA viruses.

Authors:  Robson F de Souza; Lakshminarayan M Iyer; L Aravind
Journal:  Biochim Biophys Acta       Date:  2009-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.